AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2009
Feb 27, 2009
34519_dirs_2009-02-27_99dd0b8d-96ac-4191-ac92-aade2033ed95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-02-27
Reporting Person: CRABB JOSEPH H (Director, Vice President & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-02-27 | Common Stock, par value $0.10 per share | P | 23000 | $1.3125 | Acquired | 112111 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-02-27 | Incentive stock options (right to buy) | $1.3125 | X | 23000 | Disposed | 2009-02-27 | common stock (23000) | Direct |
| 2009-02-27 | Incentive stock options (right to buy) | $1.3125 | E | 28000 | Disposed | 2009-02-27 | common stock (28000) | Direct |
Footnotes
F1: Exercisable as to one-third on March 1, 2000, one-third on March 1, 2001 and the remaining one-third on March 1, 2002.
F2: Exercisable as to one-third on March 1, 2000, one-third on March 1, 2001 and the remaining one-third on March 1, 2002.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23